Z

Zachary C. Hartman

Duke University

ORCID: 0000-0001-6549-8207

Publishes on Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research. 331 papers and 3.7k citations.

PubIndex Score59Top 41% · seniorHow it's scored

331Publications

3.7kTotal Citations

First publication: 2005First senior author: 2010

Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Monoclonal and Polyclonal Antibodies Research HER2/EGFR in Cancer Research

Top publicationsby citations

HER2 Overexpression Elicits a Proinflammatory IL-6 Autocrine Signaling Loop That Is Critical for Tumorigenesis

Zachary C. Hartman, H. Kim Lyerly|Cancer Research|2011

Cited by 136

TuNa-AI: A Hybrid Kernel Machine To Design Tunable Nanoparticles for Drug Delivery

Zilu Zhang, Daniel Reker, Christine E. Eyler et al.|ACS Nano|2025

Cited by 21

HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression

Alan Chen Chen, Zachary C. Hartman|Journal for ImmunoTherapy of Cancer|2020

Cited by 19

Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice

Timothy N. Trotter, Zachary C. Hartman|Cancer Research Communications|2024

Cited by 9

Vaccination Against Androgen Receptor Splice Variants to Immunologically Target Prostate Cancer

Robert D. Marek, Zachary C. Hartman|Vaccines|2024

Cited by 6